DENTSPLY SIRONA Inc. Files 8-K: Officer/Director Changes & More
Ticker: XRAY · Form: 8-K · Filed: 2025-02-06T00:00:00.000Z
Sentiment: neutral
Topics: officer-departure, director-election, executive-compensation, financial-reporting
Related Tickers: XRAY
TL;DR
DENTSPLY SIRONA filed an 8-K detailing leadership changes and financial updates.
AI Summary
DENTSPLY SIRONA Inc. filed an 8-K on February 6, 2025, reporting events as of February 5, 2025. The filing includes updates on the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements. It also covers Regulation FD disclosures and financial statements/exhibits.
Why It Matters
This filing signals potential shifts in the company's leadership and governance structure, which could impact strategic direction and operational oversight.
Risk Assessment
Risk Level: medium — Changes in directors or officers, especially if unexpected, can indicate underlying issues or strategic realignments that may affect the company's future performance.
Key Players & Entities
- DENTSPLY SIRONA Inc. (company) — Registrant
- February 5, 2025 (date) — Date of earliest event reported
- February 6, 2025 (date) — Date of report
FAQ
What specific officer or director positions were affected by the changes reported in this 8-K?
The filing indicates changes related to 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers,' but the specific names and positions are not detailed in the provided excerpt.
Are there any new compensatory arrangements for officers mentioned in the filing?
Yes, the filing explicitly lists 'Compensatory Arrangements of Certain Officers' as an item of information, suggesting new or updated compensation details.
Does this 8-K filing include any financial statements?
Yes, the filing lists 'Financial Statements and Exhibits' as an item of information.
What is the primary purpose of a Regulation FD Disclosure?
Regulation FD (Fair Disclosure) aims to prevent selective disclosure of material nonpublic information by requiring companies to make such disclosures publicly.
What is DENTSPLY SIRONA Inc.'s Standard Industrial Classification code?
DENTSPLY SIRONA Inc.'s Standard Industrial Classification code is 3843, which corresponds to DENTAL EQUIPMENT & SUPPLIES.
From the Filing
0000818479-25-000013.txt : 20250206 0000818479-25-000013.hdr.sgml : 20250206 20250206083224 ACCESSION NUMBER: 0000818479-25-000013 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20250205 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250206 DATE AS OF CHANGE: 20250206 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DENTSPLY SIRONA Inc. CENTRAL INDEX KEY: 0000818479 STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 391434669 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-16211 FILM NUMBER: 25595576 BUSINESS ADDRESS: STREET 1: 13320 BALLANTYNE CORPORATE PLACE CITY: CHARLOTTE STATE: NC ZIP: 28277-3607 BUSINESS PHONE: 844-546-3722 MAIL ADDRESS: STREET 1: 13320 BALLANTYNE CORPORATE PLACE CITY: CHARLOTTE STATE: NC ZIP: 28277-3607 FORMER COMPANY: FORMER CONFORMED NAME: DENTSPLY INTERNATIONAL INC /DE/ DATE OF NAME CHANGE: 19930630 FORMER COMPANY: FORMER CONFORMED NAME: GENDEX CORP DATE OF NAME CHANGE: 19920703 8-K 1 xray-20250205.htm 8-K xray-20250205 0000818479 false 0000818479 2025-02-05 2025-02-05 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 February 5, 2025 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification No.) 13320 Ballantyne Corporate Place, Charlotte North Carolina 28277-3607 (Address of Principal Executive Offices) (Zip Code) ( 844) 848-0137 (Registrant's telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share XRAY The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On February 5, 2025, upon the recommendation of the Corporate Governance and Nominating Committee (the “Governance Committee”) of the Board of Directors (the “Board”) of DENTSPLY SIRONA Inc. (the “Company”), and in accordance with the Company’s By-laws, the Board approved an increase in the number of directors from 10 to 11. Upon the further